SMMT
Summit Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
4.76 / 10Overall Score
NeturalInvestment Rating
4.76 / 10Overall Score
NeturalInvestment Rating
Is SMMT a Buy, Sell, or Hold?
- Based on a composite score of 4.76/10, we rate SMMT as a Netural. Our analysis breaks down into 3.33/10 for Fundamentals, 4.22/10 for Technicals, and 5.75/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of SMMT?
Is SMMT undervalued or overvalued?
What is the analyst consensus for SMMT?
Is SMMT a Buy, Sell, or Hold?
- Based on a composite score of 4.76/10, we rate SMMT as a Netural. Our analysis breaks down into 3.33/10 for Fundamentals, 4.22/10 for Technicals, and 5.75/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is SMMT undervalued or overvalued?
Technical Analysis of SMMT?
What is the analyst consensus for SMMT?
